Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole

Gut

Volumn 41, Issue 6, 1997, Pages 740-747

  Berstad, A E ^a   Hatlebakk, J G ^b   Maartmann Moe, H ^b   Berstad, A ^b   Brandtzaeg, P ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Atrophy; Epithelial cell proliferation; Gastritis; Helicobacter pylori; Lansoprazole; Reflux oesophagitis

Indexed keywords

LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ARTICLE; CELL PROLIFERATION; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH EPITHELIUM; TREATMENT OUTCOME;

EID: 0031454877     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.6.740     Document Type: Article

References (41)

1. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12-6.
2. Eissele R, Brunner G, Simon B, Solcia E, Arnold R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterlogy 1997;112:707-17
3. Graham DY, Genta R, Evans DG, Reddy R, Clarridge JE, Olson CA, et al. Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. Am J Gastroenterol 1997;91:2120-4.
4. Klinkenberg-Knol EC, Festen HPM, Jansen JB, Lamers CB, Nelis F, Snel P, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994;121:161-7
5. Lee A, Dixon MF, Danon SJ, Kuipers EJ, Mėgraud F, Larsson H, et al. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995;7:461-5.
6. Kuipers EJ, Uyterlinde AM, Peña AS, Hazenberg HJ, Bloemena E, Lindeman J, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1995;90:1401-6.
7. Vetvik K, Schrumpf E, Mowinckel P, Ase S, Andersen K-J. Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients. Scand J Gastroenterol 1994;29:995-1000.
8. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HPM, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
9. Kuipers EJ, Uyterlinde AM, Peña AS, Roosendaal R, Pals G, Nelis GF, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
10. Sakaki N, Momma K, Egawa N, Yamada Y, Kan T, Ishiwata J. The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer. Eur J Gastroenterol Hepatol 1995;7(suppl 1):S59-62.
11. Tatsuta M, Iishi H, Nakaizumi A, Okuda S, Taniguchi H, Hiyama T, et al. Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer 1993;53:70-4.
12. Cheli R, Santi L, Ciancamerla G, Canciani G. A clinical and statistical follow-up study of atrophic gastritis. Am J Dig Dis 1973;18:1061-5.
13. Gray MR, Darnton SJ, Hunt JA, Irlam RW, Nemeth J, Wallace HM. Accelerated gastric epithelial proliferation. Gut 1995;36:522-7.
14. Cahill RJ, Sant S, Beattie S, Hamilton H, O'Morain C. Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol 1994;6:1123-7.
15. Lynch DAF, Mapstone NP, Clarke AMT, Jackson P, Dixon MF, Quirke P, et al. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut 1995;36:351-3.
16. Cahill RJ, Xia H, Kilgallen C, Beattie S, Hamilton H, O'Morain C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 1995;40:1627-31.
17. Brenes F, Ruiz B, Correa P, Hunter F, Rhamakrishnan T, Fontham E, et al. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen, Am J Gastroenterol 1993;88:1870-5.
18. Lynch DAF, Mapstone NP, Clarke AMT, Sobala GM, Jackson P, Morrison L, et al. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 1995;36:346-50.
19. Cahill RJ, Kilgallen C, Beattie S, Hamilton H, O'Morain C. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut 1996;38:177-81.
20. Hart Hansen O, Johansen A, Larsen JK, Pedersen T, Svendsen LB. Relationship between gastric acid secretion, histopathology, and cell proliferation kinetics in human gastric mucosa. Gastroenterology 1977;73:453-6.
21. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE, Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415-21.
22. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
23. Bruno S, Darzynkiewicz Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 1992;25:31-40.
24. Hatlebakk JG, Berstad A. Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis. Aliment Pharmacol Ther 1997;11:365-72.
25. Hatlebakk JG, Berstad A, Carling L, Svedberg L-E, Unge P, EkstrÖm P, et al. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial. Scand J Gastroenterol 1993;28: 224-8.
26. Dixon MF, Genta RM, Yardley JH, Correa P, Batts KP, Dahms BB, et al. Classification and grading of gastritis the updated Sydney system. Am J Surg Pathol 1996;20: 1161-81.
27. Andersen LP, Hoick S, Povlsen CO. Campylobacter pylori detected by indirect immunohistochemical technique. APMIS 1988;96:559-64.
28. Berstad K, Wilhelmsen I, Berstad A. Biometric evaluation of gastric urease activity in man. Scand J Gastroenterol 1992;27:977-83.
29. McCormick D, Yu C, Hobbs C, Hall PA. The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology 1993;22:543-7.
30. Key G, Becker MH, Baron B, Duchrow M, Schluter C, Flad HD, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993;68:629-36.
31. Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993;104:156-70.
32. Mégraud F, Boyanova L, Lamouliatte H. Activity of lansoprazole against Helicobacter pylori. Lancet 1991;337: 1486.
33. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 1995;48: 41-5.
34. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
35. Villako K, Kekki M, Maaroos HI, Sipponen P, Tammur R, Tamm A, et al. A 12-year follow-up study of chronic gastritis and Helicobacter pylori in a population-based random sample. Scand J Gastroenterol 1995;30:964-7.
36. Sorbye H, Svanes K. Gastric mucosal protection against penetration of carcinogens into the mucosa. Scand J Gastroenterol 1995;30:929-34.
37. Lynch DAF, Clarke AMT, Jackson P, Axon ATR, Dixon MF, Quirke P. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol 1994;47: 122-5.
38. Fan XG, Kelleher D, Fan XJ, Xia HX, Keeling PWN. Helicobacter pylori increases proliferation of gastric epithelial cells. Gut 1996;38:19-22.
39. Kondo S, Shinomura Y, Kanayama S, Hagashimoto Y, Kiyohara T, Yasunaga Y, et al. Helicobacter pylori increases gene expression of hepatocyte growth factor in human gastric mucosa. Biochem Biophys Res Commun 1995;210:960-5.
40. Watson SA, Durrant LG, Crosbie JD, Morris DL. The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin. Int J Cancer 1989;43:692-6.
41. Hart Hansen O, Pedersen T, Larsen JK, Rehfeld JF. Effect of gastrin on gastric mucosal cell proliferation in man. Gut 1976;17:536-41.